A protein called DECTIN-1 may be responsible for exacerbating the severity of certain autoimmune diseases and cancer.

These results imply that using base editing to restore SMN protein levels may help SMA patients achieve long-lasting results.

Insilico Medicine has advanced into the clinic a treatment for inflammatory bowel disease (IBD) that could be the first to ...

Johnson Matthey (JM), a specialty chemicals and sustainable technologies company, reports that it has partnered with Basecamp ...

AbbVie has agreed to acquire Cerevel Therapeutics for $8.7 billion, in a deal designed to expand the buyer’s pipeline with Cerevel’s neuroscience and psychiatric drug candidates.

Researchers showed that when a section of therapeutic mRNAs is misread by cells' machinery, off-target proteins may be produced.

However, for around 10 percent of cases of frontotemporal dementia (FTD), the most common form of dementia after Alzheimer’s disease, the rogue protein hasn’t been known. Now, scientists headed by a ...

Studies suggest HDAC inhibitors could represent an effective way to treat pancreatic cancers, which have typically been very ...

TUNE-401 safely turns off both the integrated viral DNA and the extra-chromosomal cccDNA "viral factories" needed for HBV to ...

A spin-out company from the U.K.’s University of Cambridge is poised to launch a benchtop tool called Amperia for atline ...

The new method is able to identify neurons whether they are represented in images as individual points or as 3D volumes.

A team of researchers unlocked the carbohydrate-based code that governs how certain classes of proteins form themselves into the complex shapes.